Recently, down-regulation of FOXN3 has been observed in several cancer types, including hepatocellular carcinoma, oral squamous cell carcinoma, laryngeal cancer and diffuse large B-cell lymphoma [14–16]. This evidence concerns the gene FOXN3 and cancer.